June 2024 brings with it many endocrinology and diabetes conference opportunities. Notably, the Endocrine Society meeting, ENDO 2024, the American Diabetes Association (ADA) 83rd Scientific Session, and others.

ENDO 2024 is June 1-4 in Boston, MA. This year, the Endocrine Society expects over 7,000 attendees, nearly 2,000 abstracts and over 150 other sessions.

ADA’s 84th Scientific Sessions will be held June 21-24 in Orlando, FL. Organizers note that “last year’s conference brought together over 11,000 attendees, 130 speaker presentations, and 1,400 e-posters.”

ENDO 2024

• Sravani Bantu, M.D., endocrine fellow, “Extra Ocular Muscle Enlargement with Proptosis in a Patient with Nonthyroidal Illness" and “Undetectable PTH- Can it Still be Due to Primary Hyperparathyroidism?”
• Sebastian Campana, M.D., endocrine fellow, posters: Unconventional Therapy for a Patient with Latent Autoimmune Diabetes in Adults (lada), Morbid Obesity and Disease Burden: The Use of Insulin Lispro U- 200 Automated Insulin Delivery (aid) System" and “Medullary Thyroid Cancer with Persistent Elevation of Carcinoembryonic Antigen: Case Report.”
• Kristen Coutinho, Hunter Lab, poster: “Determining the Impact of Dampened Oxidative Stress on Islet Function and Gene Expression During Diabetes Onset in NOD Mice.”
• Iztiba Deeba, Hunter Lab, oral presentation: “Investigating the Regulation of Islet Alpha-cell Function Mediated by the ISL1 and LDB1 Transcriptional Complex.”
• Anitha Gondhi, M.D., endocrine fellow, posters “Decoding LADA  - A Closer at a Suspected Case Influenced By Prior IVIG Therapy," “Unilateral Spontaneous Adrenal Hemorrhage In Pregnancy," and “Inferior Petrodollars Sinus Sampling in Cushings Disease.”
• SeongHo Jo , Shalev Lab, poster: “TIX100, a Novel Small Molecule for the Treatment of MASLD/MASH.”
• Purnima Kabir, M.D., endocrine fellow, posters: “What Comes Fast, Goes Fast: Acute Megestrol Acetate Induced Adrenal Insufficiency,” and “Tumor induced Osteomalacia caused by Glomangiopericytoma.”
• Tanya Pierre, Hunter Lab, poster: “The Rnf20 Histone Modifier Is A Crucial Mediator Of Pancreatic Beta Cell Identity And Function.”

ADA 84th Scientific Sessions

• Abdulaziz Almutairi, Ramanadham Lab, oral: "Lipid Signaling in Macrophages Contributes to Inflammatory Transcriptome in Immune Cells."
• Sravani Bantu, M.D., endocrine fellow, poster: “Effects of Alcohol Consumption Among Patients with Hepatic Statuses and Prediabetes and Diabetes.”
• Sebastian Campana, M.D., endocrine fellow, poster: “Kidney Transplant Infection Risks—CGM Parameters Insights and Glucagon-Like Peptide-1 Receptor Agonist (GLP1-RA) Strategies.”
• Xiaoyong Lei, Ramanadham Lab, oral: "Transcriptional Activation in Beta-Cells During ER Stress Linking iPLA2beta with NFkB."
• Tayleur White, Ramanadham Lab and others, oral: "Intervention of Select Lipid Signaling Reduces T1D Incidence."

American Association of Clinical Endocrinology

• Purnima Kabir, M.D., Sarvani Singh, M.D., endocrine fellows, poster: “Tumor Induced Osteomalacia- A Case Series.”

Southern Society of Endocrinologists 2024 Annual Meeting

• Elizabeth Campbell, M.D., endocrine fellow, oral: “Tumor Induced Osteomalacia Caused by Glomangiopericytoma”